Corticosteroid is not beneficial in multiple‐drug combination chemotherapy for multiple myeloma
- 1 August 1993
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 51 (2) , 98-101
- https://doi.org/10.1111/j.1600-0609.1993.tb01600.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Primary dexamethasone treatment of multiple myelomaBlood, 1992
- Improved long‐term survival in multiple myelomaEuropean Journal of Haematology, 1989
- Treatment of multiple myeloma with an intensive 5‐drug combination or intermittent melphalan and prednisone; a randomised multicentre trialEuropean Journal of Haematology, 1987
- High-Dose Glucocorticoid Treatment of Resistant MyelomaAnnals of Internal Medicine, 1986
- Aggressive combination chemotherapy in multiple myeloma. A multicentre trialScandinavian Journal of Haematology, 1985
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Prednisone pulse therapy for refractory myelomaBlood, 1983
- Improved survival of increased-risk myeloma patients on combined triple- alkylating-agent therapy: a study of the CALGBBlood, 1979
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Treatment for Multiple MyelomaJAMA, 1969